Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

November 2008

November 18

ImClone Systems Announces Clearance of Tender Offer by German FederalCartel Office Genentech Issues Dear Healthcare Provider Letter Regarding a2nd Case of PML in a Raptiva Patient ACI’s FDA Boot Camp is the industry standard in providing non-regulatory professionals with the regulatory foundation critical to success Manhattan Research Releases Report on the Future of Physician Customer Service Portals AstraZeneca Appoints Rich Fante as President of its U.S. Business I'm Sticking With My Brand: Loyal Customers Perceive Competitor Ads Differently Study Finds Cost of Diabetes in the United States Exceeds $217 Billion Sanofi-Aventis Pharma S.A. Withdraws Its Application for an Extension of Indication for Taxotere and Docetaxel Winthrop (docetaxel) Public Statement on Forcaltonin - Withdrawal of the Marketing Authorisation in the European Union Telephone Counseling May Improve Effectiveness of Varenicline (Chantix), According to Free & Clear Study ACP Guideline Finds No Substantial Differences Among “Second-Generation” Antidepressants

November 19

Novartis highlights innovative approach to drug discovery with dynamic advance in exploratory pipeline Barr Announces Agreements on Nasacort AQ, Allegra D-12 and Allegra Patent Challenges ADHD Medications Do Not Cause Genetic Damage In Children Teva Receives First U.S. Approval for Generic Pulmicort Respules;Commences Commercial Launch Widely-Used Cancer Drug Associated With Significantly Increased Risk of Blood Clots Prescription Project Welcomes U.S. Appeals Court Ruling in “Data-Mining” Case Nevada Attorney General Cortez Masto Files Suit Against Hormone Therapy Drug Manufacturers IMS v. Ayotte - Physician Privacy Law Upheld as Constitutional by First Circuit Media Statement re: New Hampshire's Decision to Overturn a New Hampshire U.S. District Court Ruling that Struck Down the State’s Law Banning the Commercial Use of Prescriber-Identifiable Data AstraZeneca Enters Agreement for Authorized Generic Pulmicort Respules WebMD and Marketing Technology Solutions Terminate Merger Agreement Ambrilia Initiates Plan Aiming to Significantly Reduce its Operations in France Orion to Renew Operational Model of Pharmaceutical R&D. Negotiation Proposal on Reduction of up to 300 Employees in Finland

November 20

Pfizer Withdraws Application to Switch Viagra to Non-PrescriptionStatus in Europe BIO Congratulates Former Senator Tom Daschle on His Nomination toServe as HHS Secretary ImClone Systems' State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production FDA Advisory Committee Provides Opinion on Oritavancin for theTreatment of Complicated Skin and Skin Structure Infections AstraZeneca to Realign Supply Chain to Improve Productivity and Move Closer to Customers Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer AstraZeneca Granted Temporary Restraining Order in Pulmicort Respules Patent Litigation New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness Cervarix, GSK’s Cervical Cancer Vaccine, Wins Tender for Dutch National Immunisation Programme FDA Sends Warning Letter to Shionogi Over Cedax Direct Mailers European Medicines Agency Recommends the Suspension of the Marketing Authorisation of Ionsys (fentanyl hydrochloride) FDA Sends Letter to Protherics Over Voraxaze Web Material Internet Advertising Revenues in Q3 ’08 at Nearly $5.9 Billion
(web1)